Rhodococcus equi nosocomial meningitis cured by levofloxacin and shunt removal

Clinical Infectious Diseases

Volumn 30, Issue 1, 2000, Pages 223-224

  Scotton, P Giorgio ^a,b   Tonon, Eva ^a   Giobbia, Mario ^a   Gallucci, Maurizio ^a   Rigoli, Roberto ^a   Vaglia, Alberto ^a  

^a Regional Hospital C Foncello   (Italy)

^b Infectious Disease Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; PENICILLIN G; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; FEMALE; FOLLOW UP; HOSPITAL INFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MENINGITIS; PRIORITY JOURNAL; RHODOCOCCUS EQUI; TREATMENT OUTCOME;

ACTINOMYCETALES INFECTIONS; ANTI-INFECTIVE AGENTS; CROSS INFECTION; FEMALE; HUMANS; MENINGITIS, BACTERIAL; MIDDLE AGED; OFLOXACIN; RHODOCOCCUS EQUI; VENTRICULOPERITONEAL SHUNT;

EID: 0033979116     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313628     Document Type: Article

References (5)

1. DeMarais PL, Kocka FE. Rhodococcus meningitis in an immunocompetent host. Clin Infect Dis 1995;20:167-9.
2. Brown AE. Rhodococcus equi. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious diseases. 3d ed. New York: Churchill Livingstone, 1990:1583.
3. McNeil MM, Brown JM. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens. Eur J Epidemiol 1992;8:437-43.
4. Gerding DN, Hitt JA. Tissue penetration of new quinolones in humans. Rev Infect Dis 1989;11(Suppl 5):S1046-57.
5. Fish DN, Chow AT. The clinical pharmacokinetics of levofloxacin. Clin Pharmacokinet 1997;32:101-19.